The Wall Street Journal @WSJ
Pfizer and BioNTech began the formal process of seeking FDA clearance for a Covid-19 booster shot, submitting data showing a third vaccine dose generated higher levels of neutralizing antibodies against the original virus and its Beta and Delta variants https://t.co/BPUycg9PZw — PolitiTweet.org